Ning Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ning Wei has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Laessle
Department of General and Visceral Surgery, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Gabriel Seifert
Department of General and Visceral Surgery, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Goran Marjanovic
Department of General and Visceral Surgery, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Stefan Fichtner-Feigl
Department of General and Visceral Surgery, Center for Surgery, Medical Center University of Freiburg, Hugstetterstraße 55, 79106 Freiburg, Germany
2 shared publications - Stephan Herrmann
Department of General and Visceral Surgery, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2 shared publications - Andreas Tsouris
Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center – University of Freiburg, Freiburg, Germany
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-8
Weight Loss Measurements Under the Microscope: How Type and Baseline Definition Shape Clinical Response After Metabolic-Bariatric Surgery — A 2-Year Follow-up Analysis of 17,568 Patients
Background: In the era of modern metabolic-bariatric surgery, increasing attention is being paid to the assessment of clinical response after surgery. With the growing availability of multimodal obesity treatment, including preoperative pharmacological and lifestyle interventions, identification and optimization of factors associated with a suboptimal clinical response after metabolic-bariatric surgery (MBS) have become increasingly important. When considering weight loss specifically, two methodological factors substantially influence the interpretation of postoperative response: the metric used to quantify weight loss (percent total weight loss [%TWL] versus percent excess weight loss [%EWL]) and the baseline from which the weight-loss trajectory is calculated. Objective: To illustrate how different weight-loss metrics and baseline definitions influence the interpretation of postoperative response and the apparent association between preoperative characteristics and suboptimal clinical response after MBS. Methods: We analyzed 17,568 patients from the StuDoQ|MBE registry who underwent primary MBS and had complete 2-year postoperative follow-up data. Postoperative suboptimal clinical response was assessed using the 2024 IFSO reporting threshold of <20% TWL. Because the registry did not contain sufficiently standardized longitudinal information on improvement of obesity-related complications, the clinical component of the IFSO definition could not be incorporated. The historical threshold of <50% EWL was additionally analyzed as a surrogate criterion to facilitate comparison with previous literature. Multivariable generalized linear mixed-effects models were used to evaluate the associations of preoperative BMI and preoperative weight loss with these weight-loss-based outcomes. Analyses distinguished between cumulative weight loss, calculated from the earliest documented weight before initiation of preoperative weight reduction, and postsurgical weight loss, calculated from weight at the time of surgery to follow-up. Partial-effects plots and heatmaps were used to visualize the modeled associations. Results: The proportion of patients classified according to weight-loss-based criteria for suboptimal clinical response varied substantially according to the metric used, with more patients meeting the historical <50% EWL criterion than the IFSO-consistent <20% TWL threshold. Higher preoperative BMI was associated with a greater probability of meeting the historical <50% EWL criterion, whereas the association was reversed when suboptimal response was defined using <20% TWL. The definition of the baseline weight also substantially influenced the interpretation of preoperative weight loss. Greater preoperative weight loss was associated with a lower probability of weight-loss-based suboptimal clinical response when assessed cumulatively from the beginning of the preoperative treatment trajectory, whereas greater preoperative weight loss was associated with a higher probability of meeting the postsurgical suboptimal weight-loss criteria when weight at the day of surgery was used as the baseline. Conclusion: The choice of weight-loss metric and baseline definition substantially influences the classification of postoperative weight-loss response and the apparent association between preoperative characteristics and surgical outcomes. %EWL and %TWL are not interchangeable measures and can produce opposing interpretations of the association between baseline BMI and postoperative response. Consistent with the 2024 IFSO consensus, weight-loss assessment after MBS should use a baseline established before initiation of preoperative weight reduction where appropriate, particularly when evaluating the overall treatment trajectory. %TWL provides a more readily comparable metric for standardized reporting, whereas %EWL may remain useful for comparison with historical literature. Because clinical response after MBS is multidimensional, weight-loss thresholds should not be interpreted as synonymous with clinical treatment failure.
- 1 October 2026
- Published by Springer Nature in Obesity Surgery
- p. 1-8
Open AccessWeight Loss Measurements Under the Microscope: How Type and Baseline Definition Shape Clinical Response After Metabolic-Bariatric Surgery — A 2-Year Follow-up Analysis of 17,568 Patients
Background: In the era of modern metabolic-bariatric surgery, increasing attention is being paid to the assessment of clinical response after surgery. With the growing availability of multimodal obesity treatment, including preoperative pharmacological and lifestyle interventions, identification and optimization of factors associated with a suboptimal clinical response after metabolic-bariatric surgery (MBS) have become increasingly important. When considering weight loss specifically, two methodological factors substantially influence the interpretation of postoperative response: the metric used to quantify weight loss (percent total weight loss [%TWL] versus percent excess weight loss [%EWL]) and the baseline from which the weight-loss trajectory is calculated. Objective: To illustrate how different weight-loss metrics and baseline definitions influence the interpretation of postoperative response and the apparent association between preoperative characteristics and suboptimal clinical response after MBS. Methods: We analyzed 17,568 patients from the StuDoQ|MBE registry who underwent primary MBS and had complete 2-year postoperative follow-up data. Postoperative suboptimal clinical response was assessed using the 2024 IFSO reporting threshold of <20% TWL. Because the registry did not contain sufficiently standardized longitudinal information on improvement of obesity-related complications, the clinical component of the IFSO definition could not be incorporated. The historical threshold of <50% EWL was additionally analyzed as a surrogate criterion to facilitate comparison with previous literature. Multivariable generalized linear mixed-effects models were used to evaluate the associations of preoperative BMI and preoperative weight loss with these weight-loss-based outcomes. Analyses distinguished between cumulative weight loss, calculated from the earliest documented weight before initiation of preoperative weight reduction, and postsurgical weight loss, calculated from weight at the time of surgery to follow-up. Partial-effects plots and heatmaps were used to visualize the modeled associations. Results: The proportion of patients classified according to weight-loss-based criteria for suboptimal clinical response varied substantially according to the metric used, with more patients meeting the historical <50% EWL criterion than the IFSO-consistent <20% TWL threshold. Higher preoperative BMI was associated with a greater probability of meeting the historical <50% EWL criterion, whereas the association was reversed when suboptimal response was defined using <20% TWL. The definition of the baseline weight also substantially influenced the interpretation of preoperative weight loss. Greater preoperative weight loss was associated with a lower probability of weight-loss-based suboptimal clinical response when assessed cumulatively from the beginning of the preoperative treatment trajectory, whereas greater preoperative weight loss was associated with a higher probability of meeting the postsurgical suboptimal weight-loss criteria when weight at the day of surgery was used as the baseline. Conclusion: The choice of weight-loss metric and baseline definition substantially influences the classification of postoperative weight-loss response and the apparent association between preoperative characteristics and surgical outcomes. %EWL and %TWL are not interchangeable measures and can produce opposing interpretations of the association between baseline BMI and postoperative response. Consistent with the 2024 IFSO consensus, weight-loss assessment after MBS should use a baseline established before initiation of preoperative weight reduction where appropriate, particularly when evaluating the overall treatment trajectory. %TWL provides a more readily comparable metric for standardized reporting, whereas %EWL may remain useful for comparison with historical literature. Because clinical response after MBS is multidimensional, weight-loss thresholds should not be interpreted as synonymous with clinical treatment failure.
- 4 September 2026
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
A solitary fibrous tumor as a rare cause of a somatostatin receptor-positive pancreatic lesion
A 54-year-old female patient developed intermittent abdominal pain and diarrhea over a period of 3 days. Her general condition was good; the abdomen was soft and without significant pain on palpation. Laboratory tests and ultrasound findings were...
- 4 September 2026
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
A solitary fibrous tumor as a rare cause of a somatostatin receptor-positive pancreatic lesion
A 54-year-old female patient developed intermittent abdominal pain and diarrhea over a period of 3 days. Her general condition was good; the abdomen was soft and without significant pain on palpation. Laboratory tests and ultrasound findings were...
- Open Access
- 3 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1406-1413
Long-Term Outcomes of Pouch Resizing with Ring Augmentation for Dumping Syndrome and Weight Trajectory after Roux-en-Y Gastric Bypass: A Single-Center Experience
Introduction: Dumping syndrome (DS) and recurrent weight gain are among the most relevant long-term challenges following Roux-en-Y gastric bypass (RYGB). Several treatment strategies have been proposed, including pouch resizing with ring augmentation (PRRA). This study presents long-term outcomes of PRRA, with a focus on weight trajectory and the management of DS symptoms. Methods: A retrospective analysis of all PRRA procedures performed at a tertiary referral center between January 2008 and September 2023. Clinical data were obtained from electronic health records and patient questionnaires. Results: Sixty-two patients (90.3 % female, mean age at time of RYGB 40.2 ± 9.5 years, mean BMI 47.4 ± 7.9 kg/m 2 ) underwent PRRA at a mean interval of 56.3 ± 34.6 months after RYGB. DS was the leading indication (74.2 %), followed by recurrent weight gain (24.2 %) and primary suboptimal clinical response (1.6%). Following PRRA, 62.8 % of patients (n = 45) reported long-term improvement in DS-related symptoms, and 79 % (n = 57) achieved renewed weight loss. Long-term weight stabilization was observed, with only modest recurrent weight gain (+2.1± 5.4 kg/m 2 from post-PRRA nadir weight) after a mean follow-up of 48.6± 40.0 months. Ring removal was required in 25.8 % of patients, predominantly due to dysphagia and regurgitation. Conclusions: PRRA is an effective revisional option for managing DS symptoms after RYGB and contributes to sustained weight stability in patients with recurrent weight gain. However, ring-related adverse effects may necessitate removal in a subset of patients.
- 3 March 2026
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (4) , 1406-1413
Open AccessLong-Term Outcomes of Pouch Resizing with Ring Augmentation for Dumping Syndrome and Weight Trajectory after Roux-en-Y Gastric Bypass: A Single-Center Experience
Introduction: Dumping syndrome (DS) and recurrent weight gain are among the most relevant long-term challenges following Roux-en-Y gastric bypass (RYGB). Several treatment strategies have been proposed, including pouch resizing with ring augmentation (PRRA). This study presents long-term outcomes of PRRA, with a focus on weight trajectory and the management of DS symptoms. Methods: A retrospective analysis of all PRRA procedures performed at a tertiary referral center between January 2008 and September 2023. Clinical data were obtained from electronic health records and patient questionnaires. Results: Sixty-two patients (90.3 % female, mean age at time of RYGB 40.2 ± 9.5 years, mean BMI 47.4 ± 7.9 kg/m 2 ) underwent PRRA at a mean interval of 56.3 ± 34.6 months after RYGB. DS was the leading indication (74.2 %), followed by recurrent weight gain (24.2 %) and primary suboptimal clinical response (1.6%). Following PRRA, 62.8 % of patients (n = 45) reported long-term improvement in DS-related symptoms, and 79 % (n = 57) achieved renewed weight loss. Long-term weight stabilization was observed, with only modest recurrent weight gain (+2.1± 5.4 kg/m 2 from post-PRRA nadir weight) after a mean follow-up of 48.6± 40.0 months. Ring removal was required in 25.8 % of patients, predominantly due to dysphagia and regurgitation. Conclusions: PRRA is an effective revisional option for managing DS symptoms after RYGB and contributes to sustained weight stability in patients with recurrent weight gain. However, ring-related adverse effects may necessitate removal in a subset of patients.